This is not simply a change in ownership but a bold move. As the third largest global specialty enterprise in Over-the-counter (OTC) and Vitamin - Minerals - Supplementary Foods (VMS) worth 190 billion euros, Opella is ready to lead one of the most dynamic and flexible fields in the healthcare industry.
Opella is headquartered in France. 100 brands of enterprises such as Allegra, Dulcolax, Enterogermina, Doliprane... are widely trusted by families around the world. Based on a solid scientific foundation, deep concern for users and a commitment to sustainable development, Opella will provide multi-solution and improve access for everyone.
Ms. July Van Ongevalle - Chairman and CEO of Opella shared: "Becoming an independent enterprise is not only a meaningful milestone, but also a memorable moment for Opella. I am proud of the team of 11,000 talented personnel who have done this. Together with relevant partners and clear goals, we will reshape how people around the world proactively manage their health simply and confidently in their own way.
